Navigation Links
Radiation Control Technologies, Inc. Announces Exclusive License to Two Patents from the National Institutes of Health
Date:7/30/2012

ROCKVILLE, Md., July 30, 2012 /PRNewswire/ -- Radiation Control Technologies, Inc. (RCTI), a private development stage biopharmaceutical company developing RCT1938, a novel radiosensitizer that sensitizes tumor cells to killing by radiation while protecting healthy cells from radiation damage by inhibiting the synthesis of the novel target protein CD47, announced today that it has been granted an exclusive license to two patents from the National Institutes of Health (NIH).  The NIH exclusive license covers composition and uses of RCT1938 worldwide as a radiosensitizer to treat cancer and to treat or prevent radiation exposure in humans.

Radiation Control Technologies is entering into advanced preclinical testing of RCT1938 as an adjuvant for radiotherapy, as well as seeking federal grants and contracts to develop RCT1938 as radiation medical countermeasure.  RCT1938 promises to be a safe and effective adjuvant for radiotherapy for cancer and a promising medical countermeasure for acute radiation sickness and delayed effects of acute radiation exposure.  RCT1938 is derived from a chemical class that has been proven safe in clinical trials.

CD47, the novel target protein, is a "master switch" controlling key molecular pathways in tumor regression and radioprotection post-ionizing radiation.  By blocking the synthesis and expression of CD47, RCT1938 selectively sensitizes solid tumors to radiation killing and inhibits apoptosis (programmed cell death) in a comprehensive, multifactorial manner in healthy tissues.  More importantly, RCT1938 simultaneously activates natural survival pathways and triggers the cellular switch from apoptosis to survival in radiation injury in healthy cells.

Craig Liddell, Ph.D., CEO & President of RCTI, said, "Being awarded the NIH license is a key milestone for our company.  We believe RCT1938 will become the standard adjuvant for use in conjunction with cancer radiotherapy.  It is believed that the compound will permit lower doses of radiation to be effective and allow for higher lifetime doses of radiation with greater patient safety and fewer side effects."

"Our initial lead indication is head and neck cancer, and we believe this will be just the beginning in oncology, with RCT1938 expected to have a therapeutic role in the more than 50% of cancer patients currently treated with radiation," concluded Dr. Liddell.

AboutRadiation Control Technologies, Inc: RCTI was founded in 2011 to commercialize a top 10 scientific discovery recognized by the NIH in 2010 for the novel role of CD47 in radiosensitization of tumors cells and radioprotection of healthy cells.  RCTI was founded by a co-inventor of the licensed NIH patents, Jeffrey S. Isenberg, MD, Chair of the Scientific Advisory Board.  RCTI has assembled an experienced team of drug developers and business professionals led by CEO & President, Dr. Craig M. Liddell.

Company contact:
Dr. Craig M. Liddell
Radiation Control Technologies, Inc.
703-795-7622
cliddell@radiationcontroltechnologies.com

Media Contact:
Tiberend Strategic Advisors, Inc.
Claire Sojda
212-827-0020
csojda@tiberend.com


'/>"/>
SOURCE Radiation Control Technologies, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. West Physics Consulting Teams with Mirion Technologies Dosimetry Services Division to Deliver Radiation Detection Services
2. Fujitsu to Showcase Radiation-Hardened RFID Using FRAM Technology at Interphex 2012 in New York City, Booth #2430
3. Global Ablation Technologies Market (2011-2016) - By Application and Devices in Radiofrequency, Cryoablation, Microwave, Ultrasound, Hydrothermal, Radiation, Electrical, Light/Laser and Hydromechanical - Global Trends & Competitive Analysis
4. Avaxia Biologics is Awarded U.S. Patent for Method to Treat Radiation Damage to the Digestive Tract and Mucositis Caused by Radiation
5. ViewRay Receives FDA 510(k) Clearance for MRI-Guided Radiation Therapy System
6. Elektas Gamma Knife and Radiation Therapy Systems for Cancer Treatment Take Top Three Places in 2012s Best in KLAS for Radiation Therapy
7. Radiation Therapy in Oncology Drug Pipeline Update 2012
8. The Best Radiation Therapy Solution just got Better
9. Landauer, Inc. Appoints Peter Cempellin To President Of Landauer Radiation Measurement
10. Elekta to Showcase Revolutionary Agility Beam-shaping Innovation at Radiation Physics Annual Meeting
11. Ablation Devices Market to 2016 - (Radiofrequency, Cryoablation, Microwave, Ultrasound, Hydrothermal, Radiation, Cardiac, Cancer and Gynecology) - Global Market Forecast and Trends Analysis by Technology, Devices & Applications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... Research and Markets has announced the addition of ... report to their offering. ... The World Market for Companion Diagnostics covers the world market ... the report includes the following: , World ... Region (N. America, EU, ROW), 2015-2020 , World IVD ...
(Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, ... less invasive and more durable cerebrospinal fluid treatments, ... funding.  The Series-A funding is led by Innova ... Fund, and other private investors.  Arkis, new financing ... instrumentation and the market release of its in-licensed ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... , ... Comfort Keepers® of San Diego, CA is excited to announce they ... to drive cancer patients to and from their cancer treatments. Comfort Keepers provides ... life and ongoing independence. Getting to and from medical treatments is one of ...
(Date:6/24/2016)... ... , ... People across the U.S. are sharpening their pencils and honing their ... in which patients and their families pay tribute to a genetic counselor by nominating ... of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. , In April, ...
(Date:6/24/2016)... York, NY (PRWEB) , ... June 24, 2016 ... ... publication Haute Living, is proud to recognize Dr. Barry M. Weintraub as a ... that “the most beautiful women in the world, and the most handsome men, ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... is actively feeding the Frederick area economy by obtaining investment capital for emerging ... the past 2½ years that have already resulted in more than a million ...
(Date:6/24/2016)... Washington, D.C. (PRWEB) , ... June 24, 2016 , ... ... Pro-Am Heroes Golf Classic Tournament held on June 20th at the Woodmont Country ... local charity, Luke’s Wings, an organization dedicated to helping service members that have been ...
Breaking Medicine News(10 mins):